Delivery Order SPE2DB25D9321-SPE2DB25FQWPK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,424.46 to DMS Pharmaceutical Group Inc. for the supply of Xolair 300 mg/2 ml auto-injector vials. This firm fixed-price delivery order, issued on September 9, 2025, represents a single-unit pharmaceutical procurement with a completion date of September 30, 2025. The product will be delivered to Park Ridge, Illinois, where the vendor is based. This delivery order was issued without a set-aside designation, allowing DMS...
- The Defense Logistics Agency awarded a delivery order valued at $3,424.46 to DMS Pharmaceutical Group Inc. for Xolair 300 mg/2 ml auto-injector units. This firm fixed-price delivery order, issued on September 5, 2025, is set to be completed by September 26, 2025, with fulfillment from the vendor's location in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market despite its status as a woman-owned small...
- The Defense Logistics Agency awarded a delivery order valued at $3,424.46 to DMS Pharmaceutical Group Inc. for Xolair 300 mg/2 mL auto-injector syringes on August 19, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a specific pharmaceutical product requirement to be delivered to Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park...
- The Defense Logistics Agency awarded a delivery order valued at $3,424.46 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector units. This firm fixed-price delivery order, issued on September 3, 2025, with completion targeted for September 24, 2025, represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The company,...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for Xolair 300 mg/2 mL auto-injector vials valued at $3,424.46. The award, issued on September 3, 2025, with a completion date of September 24, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group, based in Park Ridge, Illinois, will perform the delivery at its location. This delivery order falls...
- The Defense Logistics Agency awarded a $10,273.38 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 5, 2025, for the supply of Xolair 300 mg/2 mL auto-injector vials. The contract carries an ultimate completion date of September 26, 2025, and involves delivery to Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, will fulfill this order without a set-aside designation, leveraging its...
- The Defense Logistics Agency awarded a delivery order valued at $5,136.69 to DMS Pharmaceutical Group Inc. on August 25, 2025, for the supply of Xolair 300 mg/2 ml auto-injector units. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a continuation of the agency's pharmaceutical supply chain operations. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a...
- The Defense Logistics Agency awarded a delivery order valued at $3,424.46 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector units. This firm fixed-price delivery order, issued on August 18, 2025, with an ultimate completion date of September 9, 2025, represents a specific product fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The...
- The Defense Logistics Agency awarded a delivery order valued at $6,848.92 to DMS Pharmaceutical Group Inc. for the supply of Xolair 300 mg/2 mL auto-injector vials. The contract, issued on May 30, 2025, with an ultimate completion date of June 23, 2025, operates under a firm fixed-price arrangement with no set-aside designation. The pharmaceutical product will be delivered to Park Ridge, Illinois, where the woman-owned small business vendor is headquartered. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,122.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector vials. This firm fixed-price delivery order, issued on August 26, 2025, with an ultimate completion date of September 17, 2025, carries no set-aside designation. DMS Pharmaceutical Group is performing at its Park Ridge facility and delivering...
- SPE2DB25D9321Indefinite Delivery Contract
- SPE2DB25D9321-SPE2DB25FQWPKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,424.46 to DMS Pharmaceutical Group Inc. on September 5, 2025, for the supply of Xolair 300 mg/2 ml auto-injector vials. This firm fixed-price delivery order, with an ultimate completion date of September 26, 2025, will be performed in Park Ridge, Illinois, where the vendor is headquartered. The award does not utilize a set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its status as a woman-owned small business. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and extending through November 2026. The parent contract, administered under the SPE2DB program, enables the agency to procure a comprehensive range of pharmaceutical products to support medical supply requirements across Department of Defense healthcare facilities. DMS Pharmaceutical Group, a registered pharmaceutical wholesaler since 2001, has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, biologics, and specialty medications to military health systems nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 9/5/25 |